AMGN
AMGEN INC
NASDAQ · Healthcare · Drug Manufacturers - General · US
$424.94
−1.75%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$429.96
From 52W high−4.32%
Volume2.35M
Market cap$229.74B
P/E (TTM)26.2x
P/S (TTM)6.0x
Div yield2.34%
Key dataOct 19, 2026
Open
$429.96
From 52W high
−4.32%
Volume
2.35M
Market cap
$229.74B
ValuationView details →
P/E (Fwd)
17.6x
EV/EBITDA
15.5x
P/E (TTM)
26.2x
RSI (14)
58.4
MomentumView details →
1D Return
−1.75%
YTD Return
+30.49%
SummaryUpdated Jun 1, 2026
Amgen Inc. (NASDAQ:AMGN) is one of the world's largest independent biotechnology companies, founded in 1980 and headquartered in Thousand Oaks, California. The company went public in 1983 and has grown to become a leading developer and manufacturer of human therapeutics focused on serious illnesses. Amgen operates globally, serving healthcare providers including physicians, dialysis centers, hospitals, and pharmacies through pharmaceutical wholesale distributors and direct channels. The company has built its reputation on innovative biotechnology medicines, particularly in areas where few treatment options previously existed.
Similar companies
Latest newsMore news →
AMGEN INC shares closed at $434.03, up 1.86% from the previous close.4d agoAMGEN INC shares rose 2.6% to $413.08 during the recent trading day.12d agoSPJIMR reported that all 365 participants in its Class of 2028 secured summer internships, with a median monthly stipend of ₹2 lakhs, an average of ₹1.86 lakhs and a highest stipend of ₹3 lakhs.13d ago